Univest
Univest
  • Markets

Fortis Healthcare (FORTIS) Share Price Rises 2.27% Today

  • October 7, 2026
  • Posted by: Kunal Singla
  • Category: News
No Comments
Fortis Healthcare Share Price
Fortis Healthcare Ltd. (FORTIS) share price rose to Rs 780.35 today, up 2.27% from the previous close. Market cap was Rs 57,754.3 crore.

Fortis Healthcare Share Price is trading higher today at Rs 780.35, up 2.27% from the previous close of Rs 763, with market capitalisation at Rs 57,754.3 crore. Fortis Healthcare Ltd. has moved to the day’s high of Rs 780.35 after opening at Rs 763.5 and touching a low of Rs 754. According to latest Univest data, the price event is confirmed, but no company-specific catalyst is established. For readers tracking Fortis Healthcare Share Price Today, the move is notable because it comes with a clear gap from the prior close and sits within a defined intraday range. This Fortis Healthcare Stock News update focuses on what the share price rise shows, how the valuation looks, and where the stock stands within the healthcare set-up. Univest is tracking the live move, and the same data set also helps place Fortis Healthcare Share Price in a broader stock analysis frame.

Table of Contents

Toggle
  • Fortis Healthcare Share Price Today: Price Action Analysis
  • Fortis Healthcare Ltd. (FORTIS) Fundamental Analysis
  • Sector and Industry Context
  • Peer Comparison
  • Why Investors Are Watching Fortis Healthcare
  • About Fortis Healthcare Ltd.
  • Frequently Asked Questions
    • Why is Fortis Healthcare Share Price rising today?
    • What is Fortis Healthcare Share Price today?
    • What is Fortis Healthcare market capitalisation today?
    • How does Fortis Healthcare Share Price compare with its P/E benchmark?
    • Is Fortis Healthcare Share Price expensive on P/B?
    • What do Fortis Healthcare ROE and ROCE show?
    • How does Fortis Healthcare compare with Apollo Hospitals and Max Healthcare?
    • What are the key valuation ratios for Fortis Healthcare Share Price?
  • Track Fortis Healthcare Share Price on Univest

Fortis Healthcare Share Price Today: Price Action Analysis

Metric Value
Current Price Rs 780.35
Previous Close Rs 763
Today's Move Rs 17.35 (+2.27%)
Open Rs 763.5
High Rs 780.35
Low Rs 754
Market Capitalisation Rs 57,754.3 crore
Market Cap Category Large Cap

Fortis Healthcare Ltd. (FORTIS) rose to Rs 780.35 from the previous close of Rs 763, a move of Rs 17.35 or 2.27%. The stock opened at Rs 763.5, reached a high of Rs 780.35, recorded a low of Rs 754.

Fortis Healthcare Share Price is up 2.27% today, with the stock trading at Rs 780.35 against the previous close of Rs 763. The share price rise of Rs 17.35 took the stock to the day’s high of Rs 780.35, while the low was Rs 754 and the open was Rs 763.5. That leaves Fortis Healthcare Share Price Today within a tight intraday band, and the move is being read by investors as a clear price action event rather than a headline-driven event. The market cap of Rs 57,754.3 crore keeps this Fortis Healthcare Share Price move in a sizable listed healthcare name. According to latest Univest figures, the stock is trading near the upper end of its range. For anyone following Fortis Healthcare Share Price Live, this is the key intraday setup to watch next. The next section turns to Fortis Healthcare Fundamental Analysis.

Fortis Healthcare Ltd. (FORTIS) Fundamental Analysis

Metric Value
Market Capitalisation Rs 57,754.3 crore
P/E Ratio 54.97x
P/B Ratio 5.67x
ROE 11.32%
ROCE 14.07%
EPS Rs 13.88
Book Value Per Share Rs 134.61
Dividend Yield 0.13%

Fortis Healthcare Ltd. (FORTIS) fundamental metrics show P/E 54.97x, P/B 5.67x, ROE 11.32%, ROCE 14.07%. Read together, these ratios describe the company’s position rather than a recommendation.

Fortis Healthcare Ltd. has a market capitalisation of Rs 57,754.3 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 54.97x, P/B at 5.67x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 11.32% and ROCE of 14.07%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 13.88, book value per share of Rs 134.61, dividend yield of 0.13%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 44.38x, median ROE of 13.01%, median ROCE of 15.84%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric Value
Sector Healthcare
Industry Hospital & Healthcare Services
Benchmark Scope same industry
Company P/E Ratio 54.97x
Benchmark Median P/E 44.38x
Benchmark Average P/E 97.99x
Benchmark P/E Range 6.78x to 1,602.7x
Company P/B Ratio 5.67x
Benchmark Median P/B 3.86x
Company ROE 11.32%
Benchmark Median ROE 13.01%
Company ROCE 14.07%
Benchmark Median ROCE 15.84%
Company Market Capitalisation Rs 57,754.3 crore
Benchmark Median Market Cap Rs 544.3 crore

Fortis Healthcare Ltd. (FORTIS) operates in the Healthcare sector, within the Hospital & Healthcare Services industry.

Fortis Healthcare Ltd. (FORTIS) has a P/E ratio of 54.97x, which is above the benchmark median of 44.38x, a difference of +23.86%. The P/E comparison frames valuation; it is not a signal to buy or sell.

Fortis Healthcare Ltd. (FORTIS) has a ROE of 11.32%, which is below the benchmark median of 13.01%, a difference of -12.99%. Fortis Healthcare Ltd. (FORTIS) has a ROCE of 14.07%, which is below the benchmark median of 15.84%, a difference of -11.17%.

Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.

Peer Comparison

Company Symbol Market Cap (Cr) P/E P/B ROE (%) ROCE (%)
Apollo Hospitals Enterprise Ltd. APOLLOHOSP 1,15,171.51 54.43 11.74 23.54 21.73
Max Healthcare Institute Ltd. MAXHEALTH 89,213.62 60.39 8.05 14.53 14.97
MANIPAL HEALTH ENTERPRI L MANIPALHOS 87,775.12 101.7 4.97 12.95 13.93
Aster DM Healthcare Ltd. ASTERDM 60,232.57 187.13 14.1 13.07 16.22
Global Health Ltd. MEDANTA 35,806.05 62.85 8.5 15.12 19.38

Fortis Healthcare Ltd. (FORTIS) has a P/E ratio of 54.97x compared with the displayed peer median of 62.85x. Peer multiples give relative context only, not a buy or sell view. Its ROE of 11.32% compares with a peer median of 14.53% across the companies shown in the table. ROCE stood at 14.07% versus the displayed peer median of 16.22%, providing a capital-efficiency comparison. Fortis Healthcare Ltd. (FORTIS) has a market capitalisation of Rs 57,754.3 crore. Among the 5 peers shown, 4 have a larger market capitalisation.

Why Investors Are Watching Fortis Healthcare

  • Fortis Healthcare Share Price is trading at Rs 780.35, up 2.27% from the previous close.
  • The intraday range from Rs 754 to Rs 780.35 keeps Fortis Healthcare Share Price in a clearly defined price action band.
  • Fortis Healthcare Fundamental Analysis shows a P/E of 54.97, a P/B of 5.67 and ROCE of 14.07%.
  • In the healthcare benchmark, Fortis Healthcare Share Price sits above the industry median on valuation.
  • Peer comparison shows Fortis Healthcare Share Price between lower-P/B names and higher-ROE or higher-ROCE peers.

About Fortis Healthcare Ltd.

Fortis Healthcare Ltd. operates in the Healthcare sector and the Hospital & Healthcare Services industry. The business is part of a listed peer set that includes large hospital chains, healthcare providers and diagnostics names. For readers tracking Fortis Healthcare Share Price, the company belongs to a group where valuation, return ratios and market capitalisation often differ widely across operators. Fortis Healthcare Share Price is therefore best viewed alongside its business model and peer positioning rather than in isolation. The company’s reported financial context includes EPS of 13.88, book value of Rs 134.61 and dividend yield of 0.13%, which gives a factual base for Fortis Healthcare Stock Analysis. Univest keeps this company overview tied to the broader Fortis Healthcare Stock News narrative so investors can connect the share price rise with the business footprint and valuation profile.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).

Frequently Asked Questions

Why is Fortis Healthcare Share Price rising today?

Ans. According to latest Univest data, Fortis Healthcare Share Price is rising today, but no company-specific catalyst is established. The stock is at Rs 780.35, up 2.27% from the previous close of Rs 763.

What is Fortis Healthcare Share Price today?

Ans. Fortis Healthcare Share Price is trading at Rs 780.35. The move reflects a gain of Rs 17.35, and the stock has also touched the day’s high at the same level.

What is Fortis Healthcare market capitalisation today?

Ans. Fortis Healthcare Market Cap stands at Rs 57,754.3 crore. That places Fortis Healthcare Share Price within a fairly large listed healthcare company, based on the latest Univest figures.

How does Fortis Healthcare Share Price compare with its P/E benchmark?

Ans. Fortis Healthcare Share Price is supported by a P/E of 54.97, which is above the industry median of 44.38 and below the industry average of 97.99 in the same-industry benchmark.

Is Fortis Healthcare Share Price expensive on P/B?

Ans. Fortis Healthcare Share Price is trading at a P/B of 5.67, above the industry median of 3.86 and above the industry average of 4.51. That makes valuation appear richer than the benchmark centre.

What do Fortis Healthcare ROE and ROCE show?

Ans. Fortis Healthcare reports ROE of 11.32% and ROCE of 14.07%. These figures show positive returns, though both remain below the industry medians of 13.01% and 15.84% respectively.

How does Fortis Healthcare compare with Apollo Hospitals and Max Healthcare?

Ans. Fortis Healthcare Share Price sits on a P/E of 54.97, close to Apollo Hospitals at 54.43 and below Max Healthcare at 60.39. On ROE and ROCE, Apollo is stronger, while Max is closer on ROCE.

What are the key valuation ratios for Fortis Healthcare Share Price?

Ans. Fortis Healthcare Share Price carries a P/E of 54.97, a P/B of 5.67 and an EPS of 13.88. These ratios are the main valuation markers alongside book value of Rs 134.61.

Track Fortis Healthcare Share Price on Univest

Use Fortis Healthcare Ltd. (FORTIS) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.

Track Fortis Healthcare Share Price on Univest for live updates, key valuation ratios, market capitalisation, 52-week levels and stock insights in one place. Univest brings together Fortis Healthcare Share Price Today, Fortis Healthcare Stock News and Fortis Healthcare Fundamental Analysis so readers can follow the move with context. If you are watching Fortis Healthcare Share Price Live, Univest also helps you compare the stock with sector peers and benchmark metrics as fresh market data comes in. That makes Fortis Healthcare Share Price easier to monitor alongside broader healthcare market updates.



Author: Kunal Singla
Kunal Singla is the Associate Director - Research at Univest, leading quantitative equity research, intraday trading setups, and derivatives strategy. With 4+ years of experience in Indian equity markets, he combines rigorous quantitative methods with classical technical analysis to build high-conviction research frameworks for retail and advisory clients. He holds an MSc from the Indian Institute of Technology (IIT) Delhi — one of India's most selective institutions — and has completed the Certificate in Quantitative Finance (CQF), a globally recognised programme covering derivatives pricing, risk modelling, machine learning for finance, and advanced portfolio theory. This combination places him in a small group of Indian analysts with both deep academic training in quantitative methods and SEBI-recognised research credentials. Kunal holds seven SEBI-recognised NISM certifications spanning research, derivatives, portfolio management, and securities operations: Series-XV (Research Analyst), Series-XXI-A (Portfolio Managers), Series-XVI (Commodity Derivatives), Series-VIII (Equity Derivatives), Series-VII (SORM), Series-V-A (Mutual Fund Distributors), and Series-I (Currency Derivatives). At Univest — India's SEBI-registered research and advisory platform — Kunal leads research inputs for Pro Lite, Pro Super, Pro Gold, and Pro Commodity advisory services, alongside publishing intraday stock picks on Univest Blogs.

Leave a Reply Cancel reply